Mumbai, Sept. 8 -- This agreement would mark an important milestone in advancing production and commercialisation of the HER2-positive breast cancer therapy under the country's productive development partnership (PDP) program.

Pertuzumab is a monoclonal antibody used in the treatment of HER2-positive breast cancer. Currently, the product is not manufactured locally in Brazil and is a significant expenditure for the country's Unified Health System (SUS).

Bahiafarma is a public pharmaceutical laboratory of the State of Bahia, Brazil, focused on pharmaceutical research, technological development, innovation and the production and supply of medicines and other health products, particularly for Brazil's SUS.

Bionovis is a Brazilian biotechn...